A typological model for estimation of drug and placebo effects in depression

Journal of Clinical Psychopharmacology

Volumn 22, Issue 4, 2002, Pages 414-418

  Ross, Donald C ^a   Quitkin, Frederick M ^a   Klein, Donald F ^a  

^a NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOXETINE; IMIPRAMINE; PLACEBO;

ARTICLE; CONTROLLED STUDY; DEPRESSION; DRUG RESPONSE; HUMAN; MAJOR CLINICAL STUDY; MAXIMUM LIKELIHOOD METHOD; PRIORITY JOURNAL; PROBABILITY; STATISTICAL ANALYSIS; STATISTICAL MODEL;

ANTIDEPRESSIVE AGENTS; CLINICAL TRIALS; DEPRESSIVE DISORDER, MAJOR; FLUOXETINE; HUMANS; IMIPRAMINE; MODELS, PSYCHOLOGICAL; PLACEBOS;

EID: 0036325313     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004714-200208000-00013     Document Type: Article

References (11)

1. Automaticity in clinical psychology
2. Listening to Prozac but hearing placebo: A meta-analysis of antidepressant medication
3. Identification of true drug response to antidepressants
4. Heterogeneity of clinical response during placebo treatment
5. Different types of placebo response in patients receiving antidepressants
6. Loss of drug effects during continuation therapy
7. Are drug and placebo effects in depression additive?
8. A placebo controlled study of fluoxetine vs. imipramine in the acute treatment of atypical depression
9. Columbia atypical depression: A subgroup of depressives with better response to MAOI than to tricyclic antidepressants or placebo